Global Suppression of IL-6-induced Acute Phase Response Gene Expression after Chronic in Vivo Treatment with the Peroxisome Proliferator-activated Receptor-α Activator Fenofibrate

Cited by (213)

Items 201–213 of 213

1. Peroxisome proliferator activated receptors and energy metabolism
   Philippe P. Gervois, Jean‐Charles Fruchart, Bart Staels · 2003 · CRC Press eBooks
2. Deregulation of fatty acid metabolism and cannabinoid receptors in liver of morbidly obese women with non-alcoholic fatty liver disease
   Alba Berlanga · 2015 · TDX (Tesis Doctorals en Xarxa)
3. Effects of close-up dietary energy strategy and prepartal dietary monensin on hepatic mRNA expression of enzymes involved in glucose and lipid metabolism in transition cows
   Shuowen Chen · 2013 · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
4. Role of Peroxisome Proliferator‐Activated Receptors in Inflammation and Angiogenesis
   Suchismita Acharya · 2017 · Wiley eBooks
5. Exploring a New Perspective on Treating Non-Alcoholic Fatty Liver Disease Based on Peroxisome Proliferator-Activated Receptor
   永娇 谭 · 2024 · Advances in Clinical Medicine
6. Additional file 1 of Oleoylethanolamide facilitates PPARα and TFEB signaling and attenuates Aβ pathology in a mouse model of Alzheimer’s disease
   Michele M. Comerota, Manasee Gedam, Wen Xiong, Feng Jin, Deng, Lisheng, Meng Carla Wang, Wang, Jin, Hui Zheng · 2023 · Figshare
7. Identification of hub genes related to acute kidney injury caused by sevoflurane anesthesia and endoplasmic reticulum stress
   Bin Zhou, Wenyong Peng, Dan Tong · 2025 · Open Medicine
8. Targeting Inflammation with Dietary ω-3 Polyunsaturated Fatty Acids Improved Lipid Mobilization and Flux in Heat-Stressed Wether Lambs
   Shelley A. Curry, Melanie R White, Micah S Most, Pablo Cesar C Grijalva, Rachel L Gibbs, Eileen S. Marks-Nelson, Ty B Schmidt, Dustin T Yates · 2026 · Metabolites
9. Chronic complication risk and benefits of fenofibrate in type 2 diabetes by a PPARα polymorphism (rs6008845, C/T): a FIELD trial substudy
   Andrzej S. Januszewski, Michael LH. Huang, Abubakar Mangani, Kwok Leung Ong, Chris Dalton, Rachel L. O’Connell, Lie Li, DAVID R. SULLIVAN, Dario Strbenac, Mark W. Donoghoe et al. · 2026 · Diabetes Research and Clinical Practice
10. Influence du sexe dans la susceptibilité aux hépatopathies métaboliques
    Sarra Smati · 2019 · theses.fr (ABES)
11. Emerging insights into PPARα′s role in lean metabolic dysfunction-associated steatotic liver disease: Implications for targeted therapies
    Yafei Yang, Furong Zhang, Zhuang Peng, Yafei Wu, Li Li, Zixia Shen, Qifa Ye, Jiang Yue, Shufang Na · 2026 · Acta Pharmaceutica Sinica B
12. BindingDB Entry 50040445: Diarylheptanoid glycosides from Tacca plantaginea and their effects on NF-¿B activation and PPAR transcriptional activity.
    BindingDB · 2013 · UC San Diego
13. Non-alcoholic steatohepatitis : second hit or strike out?
    Kristiaan Wouters · 2008 · Research Publications (Maastricht University)